Collected Dataset / ICoVVaC_CohortC_Baseline

The population is composed of cancer patients with solid tumours from cancer clinics at the Ottawa Hospital and at Vancouver BC Cancer, who were on chemotherapy and who are going to receive COVID-19 vaccination as part of the national vaccine roll-out (standard of care) and included in the study within 4 weeks of the second dose of vaccine.

Information on demographics, vaccine details, assessment of clinical outcomes (incidence of COVID-19) and patient self-reported COVID-19 testing results was collected. Blood samples (serum and peripheral blood mononuclear cells (PBMCs)) were collected.